Skip to content

Our Team

We are a mission-aligned team with expertise across human biology, immunology, chemistry, computational biology, data science, machine learning, drug development, clinical, and commercial leadership.

Our Purpose

We are drawn together by our shared purpose and relentless hunger to improve health outcomes for as many people as possible while reducing the growing chronic disease burden. Our approach to innovation is uniquely human-centered — unlocking connections between Anthromolecule™ chemistry and biological pathways driving disease to create solutions preferred by patients and clinicians that are designed to transform the treatment of disease.

We have brought together an inclusive, interdependently ambitious, and high-performing team with the courage to learn, iterate and make leaps together. We approach our work with humility, acknowledging and embracing the complexity of the disciplines we need to bring together and the many unknowns in human biology.

Leadership

Board of Directors

  • Portrait of Noubar Afeyan, Ph.D.

    Noubar Afeyan, Ph.D.

    Co-Founder and Board Director
    Founder & CEO, Flagship Pioneering
  • Portrait of Margo Georgiadis

    Margo Georgiadis

    Co-Founder and CEO; Board Director
  • Portrait of Ignacio Martinez

    Ignacio Martinez

    Co-Founder and Board Director
    General Partner, Flagship Pioneering
  • Portrait of Lord Ara Darzi, M.D.

    Lord Ara Darzi, M.D.

    Chair of the Board
    Director of the Institute of Global Health Innovation at Imperial College London and Chair of Imperial College Health Partners; Honorary Consultant Surgeon at Imperial College Hospital NHS Trust
  • Portrait of Phyllis Yale

    Phyllis Yale

    Board Director
    Chair of the Board, Blue Cross Blue Shield of Massachusetts and Kindred Healthcare, Inc.; Board Member, Bristol-Myers Squibb; Former Senior Partner and Leader of Healthcare Practice, Bain & Company
  • Portrait of Andreas Fibig

    Andreas Fibig

    Board Director
    Former Chairman and CEO, International Flavors & Fragrances; Former Chairman and President, Bayer Healthcare Pharmaceuticals
  • Portrait of Michael Severino, M.D.

    Michael Severino, M.D.

    Board Director
    CEO, Tessera Therapeutics; Former Vice Chairman and President, Abbvie; Former SVP and CMO, Amgen
  • Portrait of David Khougazian

    David Khougazian

    Board Director
    Growth Partner, Flagship Pioneering
  • Portrait of Jim Gilbert

    Jim Gilbert

    Board Observer
    Senior Partner, Flagship Pioneering; Former Partner and Managing Director of Global Healthcare Practice, Bain & Company
We are growing our team of individuals, looking to change the world.
View Open Positions

Our Advisors

As boundary pushers, we are amassing the leading minds across disciplines to enable our success. We are grateful for our many distinguished advisors who challenge us every day to think bigger and smarter to achieve our mission.

  • Peter Hutt

    Former Chief Counsel, FDA; Senior Counsel, Covington & Burlington LLP; Member, National Academy of Medicine

  • Jim Karkanias, Ph.D.

    CTO, Chan Zuckerberg Biohub; Former GM, Data Platform Group, Microsoft; Former Executive Director, Merck

  • Iain McInnes, Ph.D., M.B.Ch.B

    Vice Principal and Head of College of Medical, Veterinary and Life Sciences, Muirhead Chair of Medicine, Versus Arthritis Professor of Rheumatology, University of Glasgow

  • Paul Navarre

    Chairman, HTL; Chairman, Arkopharma; Board Member, LEO Pharma; Former CEO, Ferring Pharmaceuticals; Former President of International Operations and EAME, Allergan

  • Jose Ordovas, Ph.D.

    Professor and Leader of the Nutrition and Genomics Team at USDA Human Nutrition Research Center on Aging, Tufts University

  • Paul Ridker, M.D.

    Professor of Medicine, Harvard University and Brigham and Women's Hospital; Expert in inflammation and cardiovascular disease; Pioneered clinical research proving inflammation hypothesis in atherosclerosis, coronary artery disease, and more

  • Luciano Rosetti, M.D.

    CMO, Flagship Pioneering; Head of R&D, Pioneering Medicines; Former Global Head of R&D, Merck KGaA and Merck & Co.

  • Luisa Salter-Cid, Ph.D.

    CSO, Pioneering Medicines; Former CSO at Gossamer Bio; Head of Immunology, Small Molecule Immuno-Oncology, and Genomics Discovery, BMS

  • Peter Sorger, Ph.D.

    Otto Krayer Professor of Systems Pharmacology, Head of the Harvard Program in Therapeutic Sciences (HiTS), Harvard Medical School; Cofounder, Merrimack Pharmaceuticals

  • Pietro Antonio Tataranni, M.D.

    Chief Medical Officer, PepsiCo; Former SVP, Head of Medical Affairs, Diabetes and Cardiovascular, Sanofi

  • Jing-Ke Weng, Ph.D.

    Co-Founder, Double Rainbow Biosciences; Associate Professor of Biology, MIT; Member, Whitehead Institute for Biomedical Research

Join Us

We are growing our team of leaders, committed to finding breakthroughs to make a difference in as many lives as possible.
View Open Positions

Contact Us

  • Partnerships

    We welcome the opportunity to partner with experts across areas who share our passion for creating Anthromolecule medicines and want to collaborate to accelerate the development of safe, efficacious and accessible therapies across diseases.

    partnerships@montai.com

  • Press

    For media inquiries or the latest on research, thought leadership, company news, and events contact:

    press@montai.com